ATHENasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as PRNAF
ALTERITY THERAPEUTICS LTD
Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Aug 28, 2026
$2.43−0.19 (-7.25%)
Close on Oct 19, 2026
Alterity Therapeutics statistics
Financials through Jun 30, 2026, price-based ratios appear once a share price is available, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Alterity Therapeutics | Industry median |
|---|---|---|
| Market Cap | A$63.11M | A$18.21M |
| Enterprise Value | A$25.79M | A$11.71M |
Income (trailing twelve months)
| Measure | Alterity Therapeutics | Industry median |
|---|---|---|
| Pretax Income | -A$23.29M | -A$22.45M |
Balance sheet
| Measure | Alterity Therapeutics | Industry median |
|---|---|---|
| Cash & Short-Term Investments | A$37.32M | A$37.32M |
| Net Cash (Debt) | A$37.32M | A$37.32M |
| Net Cash Per Share | 0.17 AUD | 0.05 AUD |
| Working Capital | A$42.67M | A$42.67M |
Financial position
| Measure | Alterity Therapeutics | Industry median |
|---|---|---|
| Current Ratio | 14.52 | 7.26 |
| Quick Ratio | 14.26 | 5.84 |
Cash flow (trailing twelve months)
| Measure | Alterity Therapeutics | Industry median |
|---|---|---|
| Operating Cash Flow | -A$22.52M | -A$13.28M |
| Capital Expenditures | A$0 | |
| Free Cash Flow | -A$22.52M | |
| FCF Per Share | -0.10 AUD |
Efficiency
| Measure | Alterity Therapeutics | Industry median |
|---|---|---|
| Employee Count | 11 |
Dividends and yields
| Measure | Alterity Therapeutics | Industry median |
|---|---|---|
| FCF Yield | -35.7% |
Shares
| Measure | Alterity Therapeutics | Industry median |
|---|---|---|
| Shares Outstanding | 217,509,000 | 322,848,000 |
| Shares Change (YoY) | 64.5% | 28.6% |
| Float | 200,490,000 | 316,596,000 |
| Shares Held by Insiders | 7.82% | 1.94% |
| Shares Held by Institutions | 0.18% |
Taxes
| Measure | Alterity Therapeutics | Industry median |
|---|---|---|
| Income Tax | A$113.50K |
Scores
| Measure | Alterity Therapeutics | Industry median |
|---|---|---|
| Altman Z-Score | 5.14 | -0.54 |
Calculated by StockData from Alterity Therapeutics's SEC filings. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.